Akero Therapeutics (AKRO) Misses Q2 EPS by 185c

August 12, 2019 7:14 AM

Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($2.21), $1.85 worse than the analyst estimate of ($0.36).Second Quarter 2019 Financial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found